Philippines Virus Cases Exceed 300,000. Vaccines to Be Available by April 2021
The country exceeded the 300,000-case mark and slots for critical care are improving, but vaccine distribution will still take some time.
Metro Manila in the Philippines has more than half a bit of the total number of Covid-19 cases in the country. O.I. for The Subic Bay Times
The Philippines today has surpassed 300,000 Covid-19 cases as the Department of Health (D.o.H.) reported 2,747 new virus infections. The new tally marks the fifth consecutive day of the Philippines where less than 3,000 cases were reported.
Nationwide, the total of Covid-19 cases stands at 301,256, in which most patients are asymptomatic. Since the pandemic began, most cases still came from the Metro Manila or the National Capital Region (N.C.R.).
Out of the 2,747 newly reported cases, 2,471 of those patients acquired the virus in the past 14 days. A total of 852 cases were also removed from the total case count by the D.O.H.
The fatality rate of Covid-19 cases in the Philippines remain below 2% at 1.8%. The total deaths from the virus are now at 5,284 after 88 new reported deaths.
Experts from the University of the Philippines (U.P.) warned that the ease of lockdown restrictions in the Philippines may lead to a Covid-19 surge during Christmas or Holidays.
Meanwhile, in Metro Manila, the capacity for patients in need of critical care has dropped and it is a sign of improvement according to the D.o.H.
During the Laging Handa public briefing, Health Undersecretary Mario Rosario Vergeire said that the critical care utilization rate in Metro Manila.
Mr. Vergeire added that the easing of critical care utilization rate indicates that healthcare facilities are being decongested, thus having more capacity to accept more patients in need of medical attention.
As the Philippines continues to make ways to balance health, economy, and other factors before deciding on a community quarantine classification, the Philippines Food and Drug Administration (F.D.A.) said that the earliest possible availability of a coronavirus vaccine would be by April 2021.
F.D.A. Director General Eric Domingo said in a virtual press briefing said that "the best case scenario, if clinical trials are completed by December or January, and a company would file an application, then it's possible that by April 2021 that we will have an approved vaccine."